News | September 27, 2024
Sun Pharma presents clinical efficacy and safety data in severe dermatological conditions at 2024 EADV Congress
The company will also share results in two additional posters for deuruxolitinib
The company will also share results in two additional posters for deuruxolitinib
Krsnaa Diagnostics receives LoI from RINPAS for radiology services
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Focus on consolidation could help them strengthen their position in the competitive pharmaceutical industry, potentially driving expansion and improving efficiencies
Tremelimumab (Imjudo) in combination with Durvalumab (Imfinzi) is indicated for the treatment of patients with unresectable hepatocellular carcinoma
Glenmark Pharmaceuticals Limited has informed that the USFDA has issued Form 483 with zero observations
Stable profits, low leverage to keep credit profiles comfortable
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by RSV in children at high risk for RSV disease
Based out of Boston, Vivek will build on the foundation created by Vaidheesh, and will help build a stronger customer connect and further drive global expansion of the platform
USFDA concludes inspection of Dr. Reddy's Laboratories R&D centre in Bachupally with zero observation
Subscribe To Our Newsletter & Stay Updated
